Tech Company Financing Transactions
SOV Therapeutics Funding Round
SOV Therapeutics secured a $225 thousand funding round on 12/31/2011. Investors included private investors.
Transaction Overview
Company Name
Announced On
12/31/2011
Transaction Type
Venture Equity
Amount
$225,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
101 Guymon Ct.
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Not Recorded
Overview
Our proprietary oral T-replacement therapy uses testosterone undecanoate, a pro-drug of testosterone, to overcome many of the problems associated with earlier attempts to formulate and deliver oral testosterone for therapeutic treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Om Dhingra
Chief Financial Officer
Arun Shukla
Chief Scientific Officer
James Bernstein
VP - Regulatory Affairs
Craig Metz
Browse more venture capital transactions:
Prev: 12/31/2011: Hotlink venture capital transaction
Next: 12/31/2011: Wanelo venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs